活动现场共分为五大区域，特邀名医专家在义诊区现场坐诊，为群众提供问诊、开方等服务，普及 中医养生知识。中医特色专长展示区呈现针灸、推拿等传统技艺，特色理疗体验区让群众免费体验艾 灸、拔罐等服务，传统功法教学互动区带动学习八段锦、太极拳等，中医药文化体验市集则展示道地药 材、中药茶饮等产品，让民众近距离接触中医药。（记者 李丽 通讯员 张新明） 近日，聊城东阿县长寿谷聚医坊一早就热闹起来，"长寿之乡 助力健康"中医生活化大型义诊活动 暨志愿服务项目启动仪式举行。活动聚焦中医药文化传承与民生健康服务，通过"仪式启动+义诊体 验"的形式，推动中医走进日常生活。全省首个集中汇聚中医特色疗法、中医理疗和非遗传承技术的中 医特色街区"东阿聚医坊"正式亮相。当天，来自山东省中医院、聊城市中医院等专家进行义诊，吸引上 千名居民参与。 ...

福建推进特色现代农业高质量发展 中新网福州9月18日电 (郑江洛)福建省委农办主任，省农业农村厅党组书记、厅长，省乡村振兴局局长 陈明旺18日在于福州召开的新闻发布会上披露，"十四五"以来，福建省农业农村保持了稳中有进的良好 态势，预计"十四五"确定的特色现代农业发展主要指标可如期完成，为全省发展大局发挥了"压舱石"作 用。 陈明旺介绍，2021年以来全省第一产业增加值每年保持3.4%以上的增速，2024年达到3288亿元，比"十 三五"末增加556亿元；2021年以来全省农村居民人均可支配收入年均增长8.1%，2024年达到28525元， 高出全国平均水平5406元。农民收入增幅连续14年高于城镇居民收入，城乡居民收入比从2020年的 2.26：1缩小到2024年的2.06：1。 据了解，"十四五"以来，全省果茶菜、食用菌、肉蛋奶、水产品等产量逐年递增。2024年全省蔬菜产量 超过1700万吨，其中40%调供省外，是全国重要的"南菜北运"基地。2024年全省食用菌产量163万吨、 比"十三五"末增加25万吨，产量保持全国第二，银耳、绣球菌、秀珍菇等8个优势食用菌品类产量居全 国首位，成为行业的"单项冠军"。 ...

Core Viewpoint - The collaboration between Gansu Civil Aviation Logistics Company and Shenzhen Airport Logistics Development Company marks a significant advancement in air logistics, enhancing the distribution of Gansu's specialty agricultural products to coastal cities and beyond [1][2]. Group 1: Growth in Air Logistics - Gansu's specialty agricultural products transported via air cold chain increased by 47% year-on-year, with the freshness delivery rate for perishable items reaching 98% [1]. - The introduction of a "land-air combined transport + temperature-controlled traceability" model has upgraded the air logistics system, allowing for personalized storage and transportation needs [2]. Group 2: International Market Access - Gansu's traditional medicinal herbs can now reach European markets within 72 hours via Shenzhen's intercontinental cargo routes, improving delivery speed by over five times compared to traditional sea transport [2]. - The establishment of a professional cold chain distribution center in Lanzhou New Area supports the diverse temperature requirements for different products [2]. Group 3: Future Plans and Expansion - The next steps include launching dedicated cargo flights to major cities like Guangzhou and Shanghai, and exploring the integration of cross-border e-commerce with air logistics [3]. - The goal is to achieve an air transport volume of over 100,000 tons of Gansu specialty agricultural products within three years, establishing a "golden channel" for rural revitalization [3].

Core Viewpoint - The 15th Yulin Traditional Chinese Medicine Expo is being held in Yulin, Guangxi, attracting businesses to explore opportunities in the "Southern Medicine Capital" [1][3]. Group 1: Event Overview - The expo features a professional exhibition area of 70,000 square meters, showcasing renowned pharmaceutical companies, quality medicinal materials, advanced medical devices, and health products from across China [1]. - Concurrently, the 2025 Yulin Traditional Chinese Medicine Health Industry Investment Promotion Conference took place, resulting in the signing of 12 projects, including the deep processing of agarwood and an online trading platform for medicinal materials [1][3]. Group 2: Industry Significance - Yulin is a major production area for medicinal materials in Guangxi, hosting China's third-largest professional market for traditional Chinese medicine, with over 3,000 varieties and an annual transaction volume of 12 billion RMB [1]. - The city is recognized as "Southern Fragrance Capital," featuring the largest and most diverse international spice market in China [1]. Group 3: Future Development - Yulin is actively building an open platform connecting ASEAN and the global market, aiming to create a national-level health industry hub that integrates planting, processing, research, trading, exhibitions, and wellness [5]. - The Yulin Traditional Chinese Medicine Health Industry Park covers an area of 24 square kilometers and has attracted 98 enterprises, including well-known pharmaceutical companies [3].

Group 1: Business Strategy and Goals - The company aims to enhance the operational quality of existing stores, focusing on relocation and renovation rather than significantly increasing the number of stores [2] - The mid-term goal is to increase the sales proportion of non-pharmaceutical products to around 40%, with a long-term target of approximately 50% [2] - The company plans to transform over 500 stores in Yunnan this year, with pilot stores showing an increase in non-pharmaceutical sales from 15% to over 35% [2] Group 2: Business Segments - Retail business includes pharmacies, drugstores, and convenience stores, with a strong push towards non-pharmaceutical sales [2] - The Chinese medicine segment plans to increase the number of registered formula granule products from nearly 350 to an additional 100 [3] - The health and wellness segment saw a 29.3% year-on-year growth in sales, with functional foods increasing by 120% [4] Group 3: Store Transformation and Management - Over 70% of stores are categorized as multi-category pharmacies, while over 20% are specialized pharmacies [6] - The company employs a digital management system to analyze customer demographics for product selection [7] - The transformation of specialized pharmacies is yielding new growth points, particularly in specialty drugs and oncology products [8] Group 4: Financial Impact and Future Planning - The company is committed to transformation and upgrading, with minimal financial impact due to the focus on product addition and employee skill enhancement [9] - New business models will be developed in collaboration with suppliers, leveraging digital analysis for gradual store renovations [9]

Group 1: Company Performance - In 2024, the company achieved revenue of 18 billion CNY, a year-on-year increase of 3.57% [3] - Net profit attributable to shareholders was 114 million CNY, a decline of 79.23% year-on-year [3] - Total assets amounted to 16.8 billion CNY, with a net asset scale of 7.6 billion CNY [3] - In Q1 2025, revenue was 4.767 billion CNY, a decrease of 6.53% year-on-year, and net profit was 160 million CNY, down 33.83% [3] Group 2: Store Operations - As of December 31, 2024, the number of stores reached 11,498, up from 10,255 at the beginning of the year [6] - In 2025 Q1, the net number of stores decreased by 47, totaling 11,451 stores [6] - The company plans to enhance the operational quality of existing stores rather than focusing on new openings [6] Group 3: Business Development - Retail business aims to reduce reliance on medical insurance payments, targeting a decrease from 30% to below 25% [7] - The company plans to increase the number of traditional Chinese medicine products from 350 to an additional 100 [7] - The medical and health business includes light diagnosis clinics and health management centers [7] Group 4: Market Environment - The consumption market has changed significantly, affecting product demand due to various factors including online and offline dynamics [8] - The industry is experiencing intense competition, with a rapid increase in the number of pharmacies leading to lower per-store output [9] - Regulatory changes may provide consolidation opportunities for leading chain enterprises like Yixin Tang [10] Group 5: Investment and Projects - In 2024, the company repurchased 10,401,300 shares for a total of approximately 134.71 million CNY [11] - Major capital expenditures in 2025 include investments in digitalization and logistics [11] Group 6: Digitalization - The company has implemented cloud services for various operational aspects, enhancing efficiency [12] - Digital applications include customer service, product management, and supply chain tracking [12] Group 7: Medical Insurance Policies - Medical insurance payments currently account for about one-third of total revenue [13] - The company anticipates opportunities for integration and optimization due to stricter medical insurance approvals [15] Group 8: Dividend Distribution - The proposed profit distribution for 2024 is 3 CNY per 10 shares, with a total cash dividend of approximately 172 million CNY [4][19]